title: Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
authors.forename: J R
authors.initials: JR
authors.lastname: Causse
authors.forename: J
authors.initials: J
authors.lastname: Uriel
authors.forename: J
authors.initials: J
authors.lastname: Berges
authors.forename: P
authors.initials: P
authors.lastname: Bretlau
authors.forename: G E
authors.initials: GE
authors.lastname: Shambaugh
authors.forename: J B
authors.initials: JB
authors.lastname: Causse
mesh_terms: D006801:Humans; D010040:Otosclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D010498:Perilymph / Q000378:metabolism; D012969:Sodium Fluoride / Q000627:therapeutic use*; D014357:Trypsin / Q000378:metabolism*; D014361:Trypsin Inhibitors / Q000627:therapeutic use; D000515:alpha 1-Antitrypsin / Q000378:metabolism*; D000511:alpha-Macroglobulins / Q000378:metabolism*
chemical_list: D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D012969:Sodium Fluoride; D014357:Trypsin